Rush’s Use of 3-D Printed Models and Hybrid Cold Plasma in Orthopedic Oncology with Steven Gitelis, MD

The Rush Cancer Center has a deep commitment to accelerating innovations that bring cutting edge research to the bedside. Two examples of those innovations that Steven Gitelis, MD, and Rush have an active role in developing are 3-D printed models, which can help to preserve healthy tissue when treating benign and malignant bone and soft tissue tumors, and hybrid cold plasma, which can help stop the recurrence of cancer after surgery.

Related Stories